Swiss National Bank
PRME icon

Swiss National Bank’s Prime Medicine PRME Stock Holding History

Swiss National Bank’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622K Buy
178,600
+8,500
+5% +$32.4K ﹤0.01% 2251
2025
Q4 		$590K Buy
+170,100
New +$757K ﹤0.01% 2270
2023
Q2 		– Sell
-41,900
Closed -$515K – 2645
2023
Q1 		$515K Buy
+41,900
New +$683K ﹤0.01% 2512

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Swiss National Bank's PRME Position: Q1 2026 in Review

Swiss National Bank increased its Prime Medicine (PRME) stake by 5% in Q1 2026, buying an estimated $32.4K and bringing the position to 178,600 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Swiss National Bank first reported a position in PRME in Q1 2023 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Swiss National Bank held 178,600 shares of Prime Medicine worth $622K as of Q1 2026.
  • Swiss National Bank bought 8,500 Prime Medicine shares in Q1 2026, an estimated $32.4K.
  • Prime Medicine made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2251 holding.
  • Swiss National Bank first reported a position in Prime Medicine in Q1 2023 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.